National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, Bradley T., Phelps, Creighton H., Beach, Thomas G., Bigio, Eileen H., Cairns, Nigel J., Carrillo, Maria C., Dickson, Dennis W., Duyckaerts, Charles +10 more·2012·Alzheimer's & Dementia

Cited by (1,029)

Items 801–900 of 1,029

  1. Dysbiosis and Alzheimer’s Disease: Cause or Treatment Opportunity?
    Manuel H. Janeiro, María Javier Ramírez, Maite Solas · 2021 · Cellular and Molecular Neurobiology
  2. Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders
    Daniel Erskine, John‐Paul Taylor, Geor Bakker, Alastair Brown, Tim C. G. Tasker, Pradeep J. Nathan · 2019 · Drug Discovery Today
  3. CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design
    Alexis Moscoso, Thomas K. Karikari, Michel J. Grothe, Nicholas James Ashton, Juan Lantero‐Rodriguez, Anniina Snellman, Henrik Zetterberg, Kaj Blennow, Michael Schöll · 2022 · Alzheimer s & Dementia
  4. The application of nanotechnology in treatment of Alzheimer’s disease
    Yanyan Cao, Run Zhang · 2022 · Frontiers in Bioengineering and Biotechnology
  5. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
    Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, Abdel Qader Al Bawab · 2022 · Diagnostics
  6. Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer’s disease
    Algamal, Moustafa, Russ, Alyssa N., Miller, Morgan R., Hou, Steven S., Maci, Megi, Munting, Leon P., Zhao, Qiuchen, Gerashchenko, Dmitry, Bacskai, Brian J., Kastanenka, Ksenia V. · 2022 · Communications Biology
  7. Microglia directly associate with pericytes in the central nervous system
    Gary P. Morris, Catherine G. Foster, Jo‐Maree Courtney, Jessica Marie Collins, Jake M. Cashion, Lachlan S. Brown, David William Howells, Gabriele C. DeLuca, Alison Jane Canty, Anna Elizabeth King et al. · 2023 · Glia
  8. Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females
    Yi‐Ting Wang, Joseph Therriault, Stijn Servaes, Cécile Tissot, Nesrine Rahmouni, Arthur C. Macedo, Jaime Fernández Arias, Sulantha Sanjeewa Mathotaarachchi, Andréa Lessa Benedet, Jenna Stevenson et al. · 2023 · Brain
  9. Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series
    Oriol Grau‐Rivera, Ellen Gelpí, Carlos Nos, Carles Gaig, Isidró Ferrer, Albert Saiz, Albert Lladó, José Luís Molinuevo, Francesc Graus, Raquel Sánchez‐Valle et al. · 2015 · Neurodegenerative Diseases
  10. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer’s Disease
    Yannick Vermeiren, Jana Janssens, Tony Aerts, Jean‐Jacques Martin, Anne Sieben, Debby Van Dam, Peter Paul De Deyn · 2016 · Journal of Alzheimer s Disease
  11. Characteristics of the tissue section that influence the staining outcome in immunohistochemistry
    Sylwia Libard, Dijana Cerjan, Irina I. Alafuzoff · 2018 · Histochemistry and Cell Biology
  12. Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls
    Laura E. Jonkman, Yvon Galis-de Graaf, Marjolein Bulk, Eliane Kaai, Petra J. W. Pouwels, Frederik Barkhof, Annemieke J.M. Rozemüller, Louise van der Weerd, Jeroen J.G. Geurts, Wilma D. J. van de Berg · 2019 · NeuroImage Clinical
  13. Physical Activity Alleviates Cognitive Dysfunction of Alzheimer’s Disease through Regulating the mTOR Signaling Pathway
    Xianjuan Kou, Dandan Chen, Ning Chen · 2019 · International Journal of Molecular Sciences
  14. Multi-Modal Biomarkers of Repetitive Head Impacts and Traumatic Encephalopathy Syndrome: A Clinicopathological Case Series
    Breton Michael Asken, Jeremy A. Tanner, Lawren A. VandeVrede, Kaitlin Blackstone Casaletto, Adam M. Staffaroni, Nidhi S. Mundada, Corrina S. Fonseca, Leonardo Iaccarino, Renaud La Joie, Torie Tsuei et al. · 2022 · Journal of Neurotrauma
  15. The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
    Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter · 2025 · Cell
  16. Frontotemporal lobar degeneration with TDP‐43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation
    Eileen H. Bigio, Sandra Weıntraub, Rosa Rademakers, Matt C. Baker, Saman Seyed Ahmadian, ALFRED W. RADEMAKER, Bing Bing Weitner, Qinwen Mao, K.‐J. Lee, Manjari Mishra et al. · 2012 · Neuropathology
  17. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in A lzheimer's disease
    N. Allen, Andrew Robinson, Julie S. Snowden, Yvonne S. Davidson, David M. A. Mann · 2013 · Neuropathology and Applied Neurobiology
  18. The Arctic AβPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Aβ
    Hannu Kalimo, Maciej M. Lalowski, Nenad Bogdanović, Ola Philipson, Thomas D. Bird, David Nochlin, Gerard D. Schellenberg, RoseMarie Brundin, Tommie Olofsson, Rabah Soliymani et al. · 2013 · Acta Neuropathologica Communications
  19. Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease
    Sylvia E. Perez, Muhammad Nadeem, Bin He, Jennifer C. Miguel, Michael H. Malek‐Ahmadi, Kewei Chen, Elliott Jay Mufson · 2017 · Neurobiology of Aging
  20. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease
    Chelsea T. Tiernan, Stephen D. Ginsberg, Bin He, Sarah Ward, Angela L. Guillozet-Bongaarts, Nicholas M. Kanaan, Elliott Jay Mufson, Scott Counts · 2018 · Neurobiology of Disease
  21. Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer’s Disease
    Ece Bayram, Guogen Shan, Jeffrey L. Cummings · 2019 · Journal of Alzheimer s Disease
  22. Diffeomorphic Registration With Intensity Transformation and Missing Data: Application to 3D Digital Pathology of Alzheimer's Disease
    Daniel Jacob Tward, Timothy Brown, Yusuke Kageyama, Jaymin Patel, Zhipeng Hou, Susumu Mori, Marilyn Albert, Juan Carlos Troncoso, Michael I. Miller · 2020 · Frontiers in Neuroscience
  23. Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification
    Anne‐Brita Knapskog, Kristi Henjum, Ane‐Victoria Idland, Rannveig Sakshaug Eldholm, Karin Persson, Ingvild Tina Saltvedt, Leiv Otto Watne, Knut Engedal, Lars N. G. Nilsson · 2020 · Scientific Reports
  24. Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl
    Li‐Feng‐Rong Qi, Shuai Liu, Yu-Ci Liu, Ping Li, Xiaojun Xu · 2021 · International Journal of Molecular Sciences
  25. Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer’s disease
    Yanyao Deng, Hongwei Zhu, Le Xiao, Chao Liu, Yalin Liu, Wenzhe Gao · 2021 · Aging
  26. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
    Jeffrey L. Cummings, Andrew Adonay Ortiz, Janelle Castellino, Jefferson W. Kinney · 2022 · European Journal of Neuroscience
  27. Detection of Amyloid β Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer’s Disease
    C. Kerbage, Carl Sadowsky, Pierre N. Tariot, Marc Agronin, Gustavo Alva, F. Darell Turner, Dennis Nilan, Anne Cameron, Gerald D. Cagle, Paul D. Hartung · 2014 · American Journal of Alzheimer s Disease & Other Dementias®
  28. Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
    Rani, Shital, Dhar, Sudhrita Basu, Khajuria, Akhil, Gupta, Dikshi, Jaiswal, Pradeep Kumar, Singla, Neha, Kaur, Mandeep, Singh, Gurpal, Barnwal, Ravi Pratap · 2023 · Cellular and Molecular Neurobiology
  29. Preclinical Alzheimer’s disease biomarkers accurately predict cognitive and neuropathological outcomes
    Justin M. Long, Dean W. Coble, Chengjie Xiong, Suzanne E. Schindler, Richard J. Perrin, Brian Andrew Gordon, Tammie L.S. Benzinger, Elizabeth Grant, Anne M. Fagan, Oscar Harari et al. · 2022 · Brain
  30. Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease
    Hyun‐Sik Yang, Ling Teng, Daniel Kang, Vilas Menon, Tian Ge, Hilary K. Finucane, Aaron P. Schultz, Michael J Properzi, Hans‐Ulrich Klein, Lori Beth Chibnik et al. · 2023 · Nature Communications
  31. Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer’s Disease: A Diffusion Tensor Imaging Study
    Ajay A. Madhavan, Christopher G. Schwarz, Joseph R. Duffy, Edythe A. Strand, Mary M. Machulda, Daniel A. Drubach, Kejal Kantarci, Scott A. Przybelski, Robert I. Reid, Matthew L. Senjem et al. · 2015 · Journal of Alzheimer s Disease
  32. The rise and fall of insulin signaling in Alzheimer’s disease
    Belal Chami, Ariah J. Steel, Suzanne M. de la Monte, Greg Trevor Sutherland · 2016 · Metabolic Brain Disease
  33. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology
    Thomas G. Beach, Dietmar Rudolf Thal, Michelle Zanette, Adrian P L Smith, Christopher J. Buckley · 2016 · Journal of Alzheimer s Disease
  34. Alzheimer’s disease pathology and shunt surgery outcome in normal pressure hydrocephalus
    Sevil Yaşar, Ignacio Jusué-Torres, Jennifer Y. Lu, Jamie Robison, Mira A. Patel, Barbara J. Crain, Kathryn A. Carson, Jamie B. Hoffberger, Sachin Batra, Eric W. Sankey et al. · 2017 · PLoS ONE
  35. Correlative x-ray phase-contrast tomography and histology of human brain tissue affected by Alzheimer’s disease
    Mareike Töpperwien, Franziska van der Meer, Christine Stadelmann, Tim Salditt · 2020 · NeuroImage
  36. Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain
    Leon Stefanovski, Jil Mona Meier, Roopa Kalsank Pai, Paul Triebkorn, Tristram A. P. Lett, Leon Martin, Konstantin Bülau, Martin Hofmann‐Apitius, Ana Solodkin, Anthony Randal McIntosh et al. · 2021 · Frontiers in Neuroinformatics
  37. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls
    Paniz Jasbi, Xiaojian Shi, Ping S. Chu, Natalie M. Elliott, Haley Hudson, Douglas C. Jones, Geidy E. Serrano, Brandon Chow, Thomas G. Beach, Li Liu et al. · 2021 · Journal of Proteome Research
  38. Role of Mitochondria in Neurodegenerative Diseases: From an Epigenetic Perspective
    Sutong Xu, Xi Zhang, Chenming Liu, Qiulu Liu, Huazhen Chai, Yuping Luo, Siguang Li · 2021 · Frontiers in Cell and Developmental Biology
  39. Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights
    Patricia Alzola, Cristóbal Carnero Pardo, Félix Bermejo‐Pareja, Gonzalo Sánchez‐Benavides, Jordi Peña‐Casanova, Verónica Puertas‐Martín, Bernardino Fernández‐Calvo, Israel Contador · 2024 · Journal of Clinical Medicine
  40. Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern
    Vanderlinden, Greet, Ceccarini, Jenny, Vande Casteele, Thomas, Michiels, Laura, Lemmens, Robin, Triau, Eric, Serdons, Kim, Tournoy, Jos, Koole, Michel, Vandenbulcke, Mathieu et al. · 2022 · Molecular Psychiatry
  41. Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
    Tan, Rachel H., Kril, Jillian J., Yang, Yue, Tom, Nicole, Hodges, John R., Villemagne, Victor L., Rowe, Christopher C., Leyton, Cristian E., Kwok, John B.J., Ittner, Lars M. et al. · 2017 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
  42. Clinical Experience with Cerebrospinal Fluid Aβ 42 , Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia
    Leonardo Tariciotti, Matthew Casadei, Lawrence S. Honig, Andrew F. Teich, Guy M. McKhann, Giuseppe Tosto, Richard P Mayeux · 2018 · Journal of Alzheimer s Disease
  43. Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old
    Thomas Jude Montine, María M. Corrada, Claudia H. Kawas, Syed Abbas Bukhari, Lon R. White, Lü Tian, Brenna Cholerton · 2022 · Neurology
  44. Promising Blood Biomarkers for Clinical Use in Alzheimer’s Disease: A Focused Update
    Sun Ah Park, Yu Jung Jang, Min Kyoung Kim, Sun Min Lee, So Young Moon · 2022 · Journal of Clinical Neurology
  45. Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury
    Yujiao Lu, Abbas Jarrahi, Nicholas D Moore, Manuela Bartoli, Darrell W. Brann, Babak Baban, Krishnan M. Dhandapani · 2023 · Neurobiology of Disease
  46. Personalized Flexible Meal Planning for Individuals With Diet-Related Health Concerns: System Design and Feasibility Validation Study
    Maryam Amiri, Juan Li, Wordh Ul Hasan · 2023 · JMIR Formative Research
  47. Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
    Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, Federico Massa, Matteo Foschi, Giovanni Bellomo, Lorenzo Gaetani, Dietmar Rudolf Thal, Lucilla Parnetti, Markus Otto · 2024 · Brain
  48. Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease
    Ahmed Disouky, Mark A. Sanborn, K.R. Sabitha, MOSTAFA MOSTAFA, Ivan Ayala, David A. A Bennett, Yisha Lu, Yi Fu Zhou, Christopher Dirk Keene, Sandra Weıntraub et al. · 2026 · Nature
  49. Neuroimaging and the Search for a Cure for Alzheimer Disease
    Jeffrey R. Petrella · 2013 · Radiology
  50. Hippocampal α-synuclein pathology correlates with memory impairment in multiple system atrophy
    Yasuo Miki, Sandrine C. Foti, Daniela Hansen, Kate M Strand, Yasmine T. Asi, Eiki Tsushima, Zane Jaunmuktane, Andrew John Lees, Thomas T. Warner, Niall Patrick Quinn et al. · 2020 · Brain
  51. Karyopherin abnormalities in neurodegenerative proteinopathies
    Terouz Pasha, Anna Zatorska, Daulet Sharipov, Boris Rogelj, Tibor Hortobágyi, Frank Hirth · 2021 · Brain
  52. Systematic Literature Review and Meta-Analysis of Diagnostic Test Accuracy in Alzheimer's Disease and Other Dementia Using Autopsy as Standard of Truth
    Sandrine Cure, Keith R. Abrams, Mark A. Belger, Grazia Dell’Agnello, Michael Happich · 2014 · Journal of Alzheimer s Disease
  53. Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
    Li, Xiang, Liu, Qian, Xie, Xin, Peng, Cheng, Pang, Qiwen, Liu, Bo, Han, Bo · 2023 · Journal of Medicinal Chemistry
  54. Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology
    Sadhana Ravikumar, Laura E.M. Wisse, Sydney Lim, Ranjit Ittyerah, Long Xie, Madigan L. Bedard, Sandhitsu R. Das, Edward B. Lee, Matthew Dylan Tisdall, Karthik Prabhakaran et al. · 2021 · Acta Neuropathologica Communications
  55. Distinct transcriptomic responses to Aβ plaques, neurofibrillary tangles, and <i>APOE</i> in Alzheimer's disease
    Das, Sudeshna, Li, Zhaozhi, Wachter, Astrid, Alla, Srinija, Noori, Ayush, Abdourahman, Aicha, Tamm, Joseph A., Woodbury, Maya E., Talanian, Robert V., Biber, Knut et al. · 2024 · Alzheimer's &amp; Dementia
  56. The Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis
    Ashita S. Gurnani, Brandon E. Gavett · 2016 · Neuropsychology Review
  57. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-β peptides (Aβ1-42) -induced cognitive deficits in rat models of Alzheimer's disease
    Xiaoxue Zhang, Xue Wang, Xinhua Hu, Xiaowen Chu, Xintong Li, Fei Han · 2018 · Phytomedicine
  58. Alternative splicing in a presenilin 2 variant associated with Alzheimer disease
    Jacquelyn E. Braggin, Stephanie A. Bucks, Meredith M. Course, Carole Smith, Bryce L. Sopher, Leah Osnis, Kiel D. Shuey, Kimiko Domoto‐Reilly, Christina Caso, Chizuru Kinoshita et al. · 2019 · Annals of Clinical and Translational Neurology
  59. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers
    I. Koychev, M. Hofer, N. Friedman · 2020 · Journal of Nuclear Medicine
  60. TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
    C. Latimer, Jade G Stair, Joshua C. Hincks, Heather N Currey, T. Bird, C. Keene, B. Kraemer, Nicole F. Liachko · 2022 · Disease Models & Mechanisms
  61. Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain
    Dominguez, Gaëlle, Maddelein, Marie-Lise, Pucelle, Mélanie, Nicaise, Yvan, Maurage, Claude-Alain, Duyckaerts, Charles, Cuvillier, Olivier, Delisle, Marie-Bernadette · 2018 · Acta Neuropathologica Communications
  62. Differences in cognitive impairment in primary age-related tauopathy versus Alzheimer disease
    Besser, Lilah M, Mock, Charles, Teylan, Merilee A, Hassenstab, Jason, Kukull, Walter A, Crary, John F · 2019 · Journal of Neuropathology &amp; Experimental Neurology
  63. Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease
    Spiegel, Jonathan, Pirraglia, Elizabeth, Osorio, Ricardo S., Glodzik, Lidia, Li, Yi, Tsui, Wai, Saint Louis, Leslie A., Randall, Catherine, Butler, Tracy, Xu, Jinfeng et al. · 2015 · Journal of Alzheimer's Disease
  64. Adult missing persons: a concept analysis
    Claire Taylor, Penny S. Woolnough, Geoffrey L. Dickens · 2018 · Psychology Crime and Law
  65. Differential expression of m5C RNA methyltransferase genes NSUN6 and NSUN7 in Alzheimer’s disease and traumatic brain injury
    Adriana PerezGrovas‐Saltijeral, Anto Praveen Rajkumar, Helen Miranda Knight · 2023 · Molecular Neurobiology
  66. Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care
    David S. Knopman, Linda Ann Hershey · 2023 · Neurology
  67. The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus
    Jun Yup Lee, Dylan Harney, Jonathan D. Teo, John B. Kwok, Greg Trevor Sutherland, Mark Larance, Anthony Simon Don · 2023 · Molecular Neurodegeneration
  68. Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease
    Scott Counts, Bin He, John G. Prout, Bernadeta Michalski, Lucia Farotti, Margaret L. Fahnestock, Elliott Jay Mufson · 2016 · Current Alzheimer Research
  69. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease
    Marta Fernández‐Matarrubia, Jordi A. Matías‐Guiu, María Nieves Cabrera‐Martín, Teresa Moreno‐Ramos, María Valles‐Salgado, José Luis Carreras, Jorge Matías‐Guiu · 2017 · International Journal of Geriatric Psychiatry
  70. In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid‐negative individuals
    Sandhitsu R. Das, Long Xie, Laura E.M. Wisse, Nicolas Vergnet, Ranjit Ittyerah, Salena Cui, Paul A. Yushkevich, David A. Wolk, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Alzheimer s & Dementia
  71. The search for a unique Raman signature of amyloid-beta plaques in human brain tissue from Alzheimer's disease patients
    Benjamin Lochocki, Tjado H. J. Morrema, Freek Ariese, Jeroen J.M. Hoozemans, Johannes F. de Boer · 2020 · The Analyst
  72. Classification and Graphical Analysis of Alzheimer’s Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype
    Yubraj Gupta, Ji‐In Kim, Byeong Chae Kim, Goo‐Rak Kwon · 2020 · Frontiers in Aging Neuroscience
  73. Defining and predicting transdiagnostic categories of neurodegenerative disease
    Eli J. Cornblath, John L. Robinson, David John Irwin, Edward B. Lee, Virginia M.‐Y. Lee, John Q. Trojanowski, Danielle S. Bassett · 2020 · Nature Biomedical Engineering
  74. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
    Nora Bengoa‐Vergniory, Elisavet Velentza‐Almpani, Ana Maria Silva, Connor Scott, Mariana Vargas‐Caballero, Magdalena Sastre, Richard Wade‐Martins, Javier Alegre‐Abarrategui · 2021 · Acta Neuropathologica Communications
  75. Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework
    Emma E. Wolters, Alessandra Dodich, Marina Boccardi, Julie Corre, Alexander E. Drzezga, Oskar Hansson, Agneta K. Nordberg, Giovanni Battista Frisoni, Valentina Garibotto, Rik Ossenkoppele · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
  76. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer’s dementia in older persons
    Sonal Agrawal, Lei Yu, Sukriti Nag, Konstantinos Arfanakis, Lisa Laverne Barnes, David Alan Bennett, Julie A. Schneider · 2021 · Acta Neuropathologica Communications
  77. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
    Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, Ignazio Stefano Piras, Matthew J. Huentelman, Christine M. Belden, Danielle Goldfarb, David Shprecher, Alireza Atri, Charles H. Adler et al. · 2022 · Journal of Neuropathology & Experimental Neurology
  78. Alzheimer’s Disease Diagnosis by Detecting Exogenous Fluorescent Signal of Ligand Bound to Beta Amyloid in the Lens of Human Eye: An Exploratory Study
    C. Kerbage, Carl Sadowsky, Danna L. Jennings, Gerald D. Cagle, Paul D. Hartung · 2013 · Frontiers in Neurology
  79. Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology
    Asken, Breton M., Tanner, Jeremy A., VandeVrede, Lawren, Mantyh, William G., Casaletto, Kaitlin B., Staffaroni, Adam M., La Joie, Renaud, Iaccarino, Leonardo, Soleimani-Meigooni, David, Rojas, Julio C. et al. · 2022 · Neurology
  80. Neuropathology of the Common Forms of Dementia
    Rupal I. Mehta, Julie A. Schneider · 2022 · Clinics in Geriatric Medicine
  81. Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
    Bram van der Gaag, Natasja A. C. Deshayes, John J. P. Brevé, John G. J. M. Bol, Allert J. Jonker, Jeroen J.M. Hoozemans, Jean‐Philippe Courade, Wilma D. J. van de Berg · 2024 · Acta Neuropathologica
  82. Loss of calbindin-D 28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease
    Saman Seyed Ahmadian, Aras Rezvanian, Melanie Peterson, Sandra Weıntraub, Eileen H. Bigio, Marsel M. Mesulam, Changiz Geula · 2015 · Neurobiology of Aging
  83. Sensitivity and Specificity of Diagnostic Accuracy in Alzheimer’s Disease
    Joseph E. Gaugler, Robert L Kane, Joseph A. Johnston, Khaled Sarsour · 2013 · American Journal of Alzheimer s Disease & Other Dementias®
  84. Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer’s Disease Are Associated with Altered Expression of SOXB Transcription Factors
    Zaletel, Ivan, Schwirtlich, Marija, Perović, Milka, Jovanović, Mirna, Stevanović, Milena, Kanazir, Selma, Puškaš, Nela · 2018 · Journal of Alzheimer's Disease
  85. Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART)
    Miguel Quintas-Neves, Merilee Teylan, Lilah M. Besser, João Paulo Soares-Fernandes, Charles Mock, Walter A. Kukull, John F. Crary, Tiago Gil Oliveira · 2019 · Acta Neuropathologica Communications
  86. Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials
    John Tiernan O'Brien, Wolfgang H. Oertel, Ian Grant McKeith, Donald G. Grosset, Zuzana Walker, Klaus Tatsch, EDUARDO S. TOLOSA, Paul F. Sherwin, Igor D. Grachev · 2014 · BMJ Open
  87. Clinical and biological correlates of white matter hyperintensities in patients with behavioral-variant frontotemporal dementia and Alzheimer disease
    Huynh, Katharine, Piguet, Olivier, Kwok, John, Dobson-Stone, Carol, Halliday, Glenda M., Hodges, John R., Landin-Romero, Ramón · 2021 · Neurology
  88. Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology
    Suelves, Nuria, Saleki, Shirine, Ibrahim, Tasha, Palomares, Debora, Moonen, Sebastiaan, Koper, Marta J., Vrancx, Céline, Vadukul, Devkee M., Papadopoulos, Nicolas, Viceconte, Nikenza et al. · 2023 · Acta Neuropathologica Communications
  89. Neuropathology of the Alzheimer's continuum: an update
    K. A. Jellinger · 2020 · Free Neuropathology
  90. Multi-scale neural decoding and analysis
    Hung‐Yun Lu, Elizabeth S. Lorenc, Hanlin Zhu, Justin Kilmarx, James S. Sulzer, Chong Xie, Philippe N. Tobler, Andrew J. Watrous, Amy L. Orsborn, Jarrod A. Lewis‐Peacock et al. · 2021 · Journal of Neural Engineering
  91. Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
    Xiaoying Ma, Ying Zhao, Tao Yang, Na Gong, Xun Chen, Guoli Liu, Jun Xiao · 2022 · Frontiers in Aging Neuroscience
  92. Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
    Zaida L. Almeida, Daniela C. Vaz, Rui M. M. Brito · 2024 · Molecular Neurobiology
  93. Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer’s disease: a hypothesis
    Heiko Braak, Kelly Del Tredici · 2013 · Acta Neuropathologica
  94. Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings
    Adrian L. Oblak, Matthew C. Hagen, Kathleen J. Sweadner, Ihtsham ul Haq, Christopher T. Whitlow, Joseph A. Maldjian, Francine Epperson, Jared Cook, Mark A. Stacy, Jill R. Murrell et al. · 2014 · Acta Neuropathologica
  95. Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly
    Zhiping Mi, Willi M. Halfter, Eric E. Abrahamson, William Edward Klunk, Chester A. Mathis, Elliott Jay Mufson, Miloš D. Ikonomović · 2016 · Journal of Neuropathology & Experimental Neurology
  96. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
    Gabriel Martínez, Robin W.M. Vernooij, Paulina Fuentes Padilla, Javier Zamora, Leon A Flicker, Xavier Bonfill · 2017 · Cochrane Database of Systematic Reviews
  97. Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
    M. Pontecorvo, C. Keene, T. Beach, T. Montine, Anupa K. Arora, Michael D. Sr Devous, Michael A. Navitsky, I. Kennedy, Abhinay D. Joshi, Ming Lu et al. · 2020 · EJNMMI Research
  98. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
    Carla Abdelnour Ruiz, Daniel Ferreira, Ketil Oppedal, Lena Cavallin, Olivier Bousiges, Lars‐Olof Wahlund, Jakub Hort, Zuzana Nedelská, Alessandro Padovani, Andrea Pilotto et al. · 2020 · NeuroImage Clinical
  99. Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson’s disease
    Stefanie Smolders, Stéphanie Philtjens, David Crosiers, Anne Sieben, Elisabeth Hens, Bavo Heeman, Sara Van Mossevelde, Philippe Pals, Bob Asselbergh, Roberto A. Dias et al. · 2021 · Acta Neuropathologica Communications
  100. Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2 : A genome‐wide association study in over 12,000 non‐demented participants
    Vincent Damotte, Sven J. van der Lee, Vincent Antoine Chouraki, Benjamin Grenier‐Boley, Jeannette M Simino, Hieab H.H. Adams, Giuseppe Tosto, Charles C. White, Natalie Terzikhan, Carlos Cruchaga et al. · 2021 · Alzheimer s & Dementia